[10 years' results of combined modality therapy of cervix cancer].
The study was concerned with 5 and 10-year results of combination treatment (surgery + radiation) of 304 cases of cervical cancer. Recurrence and metastases developed in 32 patients (10.5%). The 5-year survival rate for cases with stage I tumor was 95.1% and stage II--90.5%. At 10 years, the said rates were 95.1 and 84.7%, respectively. Minimal effective dose was found to be 1,330 reu.
D000328:Adult; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*
Desiatiletnie rezul'taty kombinirovannogo lecheniia raka sheĭki matki.